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Abstract Expression of Na+ channel protein was analysed in
established cell lines of rat and human prostatic carcinoma origin
by flow cytometry using a fluorescein-labelled polyclonal anti-
body. In many cell lines examined, the obtained frequency
distribution profiles were bimodal and identified a subpopulation
of cells which expressed high levels of Na+ channel protein. A
significant positive correlation was demonstrated between the
proportion of channel-expressing cells and the functional ability
of individual cell lines to invade a basement membrane matrix in
vitro. In addition, two transfectant cell lines containing rat
prostate cancer genomic DNA were found to express signifi-
cantly elevated levels of Na+ channel protein when compared
with the original benign recipient cell line. Enhanced Na+ channel
expression by two metastatic derivatives of these transfectant
cells directly correlated with increased invasiveness in vitro.
These studies strongly support the hypothesis that expression of
Na+ channel protein and the metastatic behaviour of prostatic
carcinoma cells are functionally related, either by endowing the
membranes of these cells with specialised electrophysiological
properties (e.g. enhancing their motility and/or secretory
activities) and/or by perturbing endogenous mechanisms regulat-
ing ionic homeostasis within the cells.
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1. Introduction
Voltage-activated Na channels have been implicated in a
range of cellular activities including proliferation, migration,
adhesion and the cell cycle in addition to their recognised role
in neural conduction and muscle contraction [1]. In prostatic
carcinoma, recent evidence has suggested that the number of
Na channels expressed within the plasma membrane may be
related to metastatic potential. Electrophysiological patch-
clamp experiments revealed Na channels to be present in
approximately 47% of highly metastatic MAT-LyLu cells of
rat but absent from the related but poorly metastatic AT2
cells [2]. In the former, the electrical activity of plasma mem-
brane-located Na channels, and the ability of the cells to
invade basement membrane matrix in vitro, was inhibited
by tetrodotoxin, a speci¢c blocker of voltage-gated Na chan-
nel activity [2]. These ¢ndings were supported by similar ex-
periments on analogous human prostate carcinoma cell lines
LNCaP and PC3. The former, which is not metastatic in nude
mice, expressed no Na channels, as detected by electrophysi-
ology, Western blotting or £ow cytometry. In contrast, ap-
proximately 10% of cells from the highly metastatic PC3 cell
line expressed functionally active Na channels which could
also be detected by £ow cytometry of cells labelled with a
£uorescent antibody to Na channel protein [1].
In the present study, we have employed £ow cytometry to
measure expression of Na channel protein in a large series of
behaviourally distinct prostatic epithelial cell lines. Seven of
these (Table 1) were variants of the Dunning rat prostate
carcinoma model which display a broad range of metastatic
activity from 6 5% to s 75% when inoculated subcutane-
ously into syngeneic rats [3]. We also examined three cell lines
originally isolated from human prostate carcinoma metastases
and one derived from human non-neoplastic prostatic epithe-
lium. In each case, an important hallmark of malignancy,
namely the ability to invade the basement membrane, was
assessed by an in vitro invasion assay. In this way we aimed
¢rstly to determine whether the level of Na channel protein
expression correlated with metastatic potential of prostatic
carcinoma cells.
A second aim of the study was to determine whether con-
version of cells from a benign to a malignant phenotype is
accompanied by Na channel protein expression. We have
employed £ow cytometry to analyse a series of transfectant
cell lines containing rat prostate cancer genomic DNA se-
quences that we have recently developed [4]. These cells
were speci¢cally selected for their metastatic behaviour when
inoculated into syngeneic hosts. A ¢nal aim of the investiga-
tion was to determine whether cells expressing Na channels
might represent a distinct population with an immutable phe-
notype, or whether they exist in equilibrium with their non-
expressing neighbours. This involved using the sorting facility
of the £ow cytometer to separate cells of high Na channel
expression from the remainder and then analyzing the two
fractions independently.
2. Materials and methods
2.1. Cell cultures
Sixteen cell lines were grown for £ow cytometric analysis and in-
vasion assay. Of these, seven comprised sublines of the Dunning
R3327 rat prostate carcinoma originally isolated from a spontaneous
tumour in a rat [3,5]. These cell lines (Table 1) have been well char-
acterised and display metastatic activity in syngeneic Copenhagen
male rats ranging from 6 5% to s 75% [3,6,7].
2.2. Human cell lines
Four cell lines of human prostate were also used, three of which
(Du145, LNCaP and PC3) were derived from human prostatic carci-
noma metastases [8^10]. The fourth, PNT2, was derived from normal
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human prostatic epithelium immortalised by transfection with SV40
replication defective genome [11,12]. These, and the Dunning cell
lines, were grown in RPMI 1640 medium supplemented with 2 mM
L-glutamine, 10% fetal calf serum (FCS), 100 U/ml penicillin, 0.1 mg/
ml streptomycin (Gibco) and 0.05 Wg/ml each of hydrocortisone and
testosterone (Sigma).
2.3. Transfectant cell lines
Four novel cell lines were previously generated in this laboratory by
transfecting genomic DNA from rat prostatic tumour cells into a
recipient benign cell line [4]. RMP1 cells were obtained by transfecting
DNA from Dunning rat prostate G cells into rat benign mammary
epithelial cell line RAMA 37 [13]. A subline of malignant cells derived
from RMP1, designated RMP1a-lu, was generated by inoculating the
parental cells into the mammary fat pad of Wistar-Furth rats and
culturing cells isolated from a subsequent pulmonary metastasis [4].
RMP2 was produced by transfecting genomic DNA from Dunning
AT6.1 into RAMA 37 cells. Thereafter, the RMP2c-lu subline was
isolated from a pulmonary metastasis derived from the same cells
inoculated into rats [4]. The recipient cell line, RAMA 37, was also
grown as a non-malignant control with which the transfectant cells
could be compared. All ¢ve of these cell lines were grown in Dulbec-
co’s modi¢ed Eagle’s medium (DMEM) supplemented with 10% FCS,
8 mM L-glutamine, 0.05 Wg (1370 IU)/ml insulin, 0.05 Wg/ml dexa-
methasone and the above antibiotics. All cell lines were kept at
37‡C in a humidi¢ed atmosphere of 5% CO2 and air. Medium was
changed thrice weekly and cells harvested when approximately 75%
con£uent.
2.4. Na+ channel antibody
The antibody used to label cells was a rabbit immunoa⁄nity puri-
¢ed polyclonal IgG fraction (Upstate Biotechnology Inc.) raised
against a 19 residue synthetic peptide corresponding to a highly con-
served intracellular loop of vertebrate Na channel [14].
2.5. Flow cytometry
Viable cells were used for £ow cytometric measurement of Na
channel protein expression. Tissue culture monolayers were released
from 14 cm diameter culture dishes using 0.03% trypsin phosphate
bu¡ered saline (PBS) containing 0.02% EDTA for 4 min at 37‡C after
which the cells were transferred to a centrifuge tube and gently agi-
tated by pipetting to obtain a single-cell suspension, which was con-
¢rmed microscopically. This ensured that a monodisperse suspension
of cells was produced whilst reducing the contact with trypsin to a
minimum. The activity of trypsin was then arrested with FCS, the
cells washed in medium, resuspended in complete medium and an
aliquot counted using a haemocytometer.
A volume of cell suspension containing 1U106 cells from each cell
line was transferred to separate 1.5 ml microfuge tubes, the cells
washed with 1 ml of PBS and supernatants replaced with 200 Wl of
blocking bu¡er comprising PBS containing 1% bovine serum albumin
and left on ice for 10 min. To each supernatant was added 100 Wl of
Na channel antiserum (Upstate Biotechnology Inc.) from a stock
solution containing 12.5 Wg protein per ml of blocking bu¡er. Neg-
ative control tubes containing the same number of cells received 100
Wl of either blocking bu¡er alone or antibody preabsorbed with an
excess of immunising peptide (Upstate Biotechnology Inc.). Both sets
of tubes were incubated on ice for 1 h with mixing every 15 min. After
centrifuging, the antiserum was withdrawn, the cells washed with 1 ml
of PBS and 100 Wl of anti-rabbit (goat IgG)-FITC conjugate, diluted
1:160 in blocking bu¡er was added to each of the tubes, including
controls. Incubation occurred for a further hour on ice after which the
supernatants were replaced with PBS. Fluorescence intensity was
measured using a Becton Dickinson FACSort £ow cytometer (San
Jose, CA, USA) and analysed using Lysis software. Sensitivity of
the instrument was adjusted so that the mean intensity of the negative
controls fell within the ¢rst log decade with, at most, 5% lying above
this range. Preabsorption of the antibody with antigen quenched all
activity so that readings from these samples were closely similar to
those in which the primary antibody had been omitted altogether. A
total of 20 000 events were counted for each sample with electronic
noise and sub-cellular debris excluded by setting a threshold on for-
ward light scatter (representing cell volume). This procedure was per-
formed on each cell line in two separate analyses and the average
value calculated. Data were recorded as frequency distribution histo-
grams, mean £uorescence intensity and the percentage of cells with an
intensity greater than that of 95% of controls (proportion of cells
positive for Na channels). Suitable £uorescence histograms were
subjected to a deconvolution programme. This was achieved by ap-
plying an equation of the algebraic sum of the two Gaussian distri-
butions utilising data lying between the peak of the larger, left-hand
population and the end of the tail of the secondary population. A
curve-¢tting routine [15] using the Levenberg-Marquardt algorithm
[16] adjusted the parameters to minimise the value of chi-square be-
tween the computed and the actual histograms. The procedure was
halted when the di¡erence between approximations was less than 0.01.
2.6. Invasion assays
The ability of each of the cell lines to invade a basement membrane
matrix was measured using an established in vitro invasion assay
[1,2,17]. Extracellular matrix (ECM, Sigma) was diluted 1:2 with
DMEM and 15 Wl applied to the membrane of 12 mm diameter
Millicell ¢lter inserts with a pore diameter of 12 Wm (Millipore).
The £uid was spread evenly over the upper surface of the polycar-
bonate ¢lter with a ¢ne glass rod and the inserts heated to 37‡C for 10
min to polymerise the gels which comprised 100 Wg protein per cm2 of
¢lter surface.
Cells from each cell line to be analysed in the invasion assays were
harvested with trypsin/EDTA and suspended in DMEM containing
dialysed and stripped FCS (1% v/v) such that there were 6.2U104 cells
per ml. 0.4 ml of this cell suspension (4.2U104 cells/cm2) was dis-
pensed into each Millicell ¢lter insert in triplicate, the inserts placed
in a 24-well multiwell plate (Nunclon) and each well ¢lled with 0.6 ml
of identical medium. The plates were incubated at 37‡C for 48 h after
which non-invading cells were wiped from the upper surface of the
¢lters with a cotton bud. The dislodged cells were aspirated and re-
placed with 0.4 ml medium. The wells were ¢lled with 480 Wl of
medium plus 120 Wl of a solution containing 5 mg/ml of 3-[4,5-dimeth-
ylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT, Sigma). The
cells were incubated with MTT for 5 h after which the £uid was
removed and the formazan dye dissolved with 400 Wl of dimethyl
sulphoxide at 37‡C for 10 min. Aliquots of 195 Wl were transferred
in duplicate from each well to a 96-well microtitre plate and the
optical absorbance measured with a Multiskan MS plate reader using
a ¢lter of 570 nm. A standard curve of optical absorbance against cell
number for each cell line was constructed by seeding serially diluted
cells of known number into a 24-well plate with DMEM and 1%
stripped FCS and leaving them to attach for 24 h at 37‡C. The
MTT assay was then performed as described above. Optical absorb-
ance of each triplicate invasion assay was converted into cell number
by regression analysis of the linear part of the curve and the mean and
standard deviation calculated.
2.7. Cell sorting
Two samples of 2U106 cells from each of AT3 and MAT-LyLu
were labelled with antibody to detect Na channel protein expression,
as described (see Section 2.5) above. The cells were passed through the
£ow cytometer which had previously been sterilised with isopropyl
alcohol followed by lengthy purging with sterile distilled water. The
resultant frequency distribution histograms of £uorescence were bimo-
dal and so a threshold was set to coincide with the trough between the
peaks. Cells with a £uorescence intensity above this line were sorted
from one sample of each pair, and cells with a lower intensity were
collected from the other using the piezo electric sorting facility. The
subpopulations of cells were grown to near con£uence and subcul-
tured at a split ratio of 1:4. When 75% con£uent the cells were har-
vested, labelled with antibody to Na channel protein and re-analysed
£ow cytometrically using an identical procedure.
3. Results
3.1. Dunning rat cell lines
Flow cytometric frequency distribution histograms of cells
labelled for Na channel protein expression in the seven phe-
notypically distinct cell lines of the Dunning rat prostate car-
cinoma model, together with their respective negative con-
trols, are shown in Fig. 1. The two weakly metastatic cell
lines (G and AT1) exhibited £uorescence pro¢les coincident
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with those of the controls. Cell line AT2, which has a low to
moderate metastatic ability, exhibited a distribution pattern
largely coincident with its control except for a small enhanced
forward scatter of increased immuno£uorescence. In contrast,
analysis of the two highly metastatic cell lines (AT3 and
MAT-LyLu) revealed distinct bimodal distributions (Fig. 1).
The mode of the principal peak coincided with that of the
controls while a secondary, smaller peak, represented a sub-
population of cells with a high level of Na channel protein
expression. The remaining two cell lines (AT6.1 and MAT-Lu)
exhibited little di¡erence from their respective controls (Fig.
1).
Since the modes of the larger frequency distribution peaks
for both labelled and control cells were coincident, mean val-
ues of £uorescence intensity di¡ered little between the seven
cell lines. Therefore, these data have not been included. How-
ever, greater di¡erences were revealed when the data were
expressed as the proportion of cells with positive immuno£uo-
rescence (Table 1). Furthermore, a highly signi¢cant (P6 0.01)
positive correlation was found between the proportion of Na
channel immunopositive cells and the percentage of invading
cells deduced from the in vitro invasion assay (Fig. 2).
3.2. Human cell lines
Data obtained from the four human prostate cell lines are
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Fig. 1. Flow cytometric frequency distribution histograms of immu-
no£uorescence for Na channel protein from seven cell lines of the
Dunning rat prostate carcinoma model. In each case, plots of both
control and labelled cells are overlayed with the latter indicated by
arrows where there is a clear distinction between the two lines. In
these and Figs. 3 and 4, £uorescence intensity units are represented
on the logarithmic abscissae which include two log decades and the
numbers of cells are on the ordinate which spans 200 events.
Fig. 2. Graphic plots showing the relationships between the percent-
age of invading cells versus the percentage of Na channel-positive
cells for the two di¡erent groups of cell studied (n = 7, each). Open
symbols/dotted line, the Dunning rat prostatic cancer cell lines;
closed symbols/solid line, human prostate cancer cell lines and the
RAMA 37 cell line transfected with rat prostate cancer cDNA (up
to 12.4% invading cells). Linear regression analyses gave correlation
coe⁄cients of 0.97 for the Dunning cells; and 0.83 for the human
prostate cancer and transfectant cell lines. The regressions were sta-
tistically signi¢cant for both groups of cells (P6 0.01 and P6 0.05,
respectively).
Table 1
Proportion of cells positive for Na channels by £ow cytometry and results of invasion assay for cells of the Dunning rat series







% of total cellsb
G None to low 5.8 0.0 ^
AT1 Low 5.7 3.5 (1.02) ^
AT2 Low to moderate 8.3 17.0 (3.11) 5.1
AT6.1 High 7.2 9.9 (2.01) ^
AT3 High 15.3 22.3 (2.25) 35.2
MAT-Lu High 8.9 7.9 (0.99) ^
MAT-LyLu High 18.1 27.2 (7.40) 25.6
Figures in parentheses represent þ one standard deviation from the mean.
aFrom Isaacs et al. [3].
bAs derived from deconvolution of frequency distribution histograms.
P. Smith et al./FEBS Letters 423 (1998) 19^24 21
shown in Table 2A. Of the three malignant cell lines, moder-
ate Na channel expression by both Du145 and PC3 cells was
found whereas in LNCaP cells channels were scarce. Fre-
quency distributions of immuno£uorescence for Du145 and
PC3 were both bimodal with a considerably larger secondary
peak in the latter. These di¡erences were re£ected in their
scores by invasion assay. The immortalised normal prostatic
epithelial line PNT2 showed no ability to invade basement
membrane matrix and yet 13.7% of its cells were immunopos-
itive.
3.3. Transfectant cell lines
Flow cytometric frequency distributions for the cells trans-
fected with DNA from Dunning rat prostate carcinoma cells
are shown in Fig. 3. Pro¢les for the two cell lines derived from
in vitro passage of the transfected cells (RMP1 and RMP2)
were similar and showed prominent bimodal distributions.
The two cell lines isolated from pulmonary metastases of
the transfectants were also bimodal but the secondary peaks
were larger suggesting that the size of the subpopulation of
cells expressing Na channels had increased.
Numerical data from these cell lines (Table 2) con¢rm that,
in both instances, the proportion of immunopositive cells was
enhanced in the metastatic lines when compared to their pro-
genitors. Similarly, their capacity to invade basement mem-
brane matrix was also increased. Taking the human prostate
cancer and the transfected cell lines together, the data sug-
gested that the correlation between the proportion of Na
channel immunopositive cells and the percentage of invading
cells to be signi¢cant (P = 0.05) up to and including 12.4% of
cells being invasive (Fig. 2). Accordingly, signi¢cant invarices
would occur when more than 11.8% of the cells are Na
channel-positive.
3.4. Deconvolution of histograms
The frequency distribution histograms which showed a bi-
modal distribution were subjected to a deconvolution pro-
gramme resolving them into two distinct histograms which
could be analysed independently, as detailed in Section 2.
The number of positive cells included in the secondary pop-
ulation is expressed as a percentage of the total cell popula-
tion in Tables 1 and 2.
3.5. Cells sorted by £ow cytometry
Flow cytometry was used to separate cells expressing high
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Table 2
Proportion of cells positive for Na channels by £ow cytometry and results of invasion assay for human prostate cancer cell lines and transfec-
tant cell lines
Cell line Percentage of positive cells Percentage of invading cells Secondary population as % of
total cellsa
A PNT2 13.7 0.0 ^
LNCaP 1.6 0.0 ^
Du145 13.8 5.2 (0.93) 19.4
PC3 18.8 10.0 (1.12) 45.6
B RAMA 37 9.7 14.4 (1.61) ^
RMP1 17.8 8.8 (0.88) 16.0
RMP1a-lu 19.3 20.0 (4.48) 19.8
RMP2 15.5 8.0 (1.70) 14.9
RMP2c-lu 35.2 12.4 (1.74) 35.8
Figures in parentheses represent þ one standard deviation from the mean.
aAs derived from deconvolution of frequency distribution histograms.
Fig. 4. Flow cytometric frequency distribution pro¢les of AT3 cells
sorted into high and low £uorescence fractions, grown for several
population doublings and then reassessed by £ow cytometry. De-
scendents of the low £uorescence fraction (AT3 LO) produced a
unimodal distribution with a narrow ‘tail’ of positive cells. The dis-
tribution for cells descended from the high £uorescence fraction
(AT3 HI) is distinctly bimodal representing a large subpopulation
of positive cells.
Fig. 3. Flow cytometric frequency distribution pro¢les from trans-
fectant cell lines as described in the text. Cells derived by direct in
vitro passage of the products of transfection, RMP1 and RMP2,
both show bimodal distributions with a small secondary peak of
positively £uorescent cells. Cells derived from pulmonary metastases
of the transfectants in rats, RMP1a-lu and RMP2c-lu, are also bi-
modal but the secondary peak is enlarged suggesting an increased
sub-population of cells expressing Na channels. In each case the
larger, left-hand peak was coincident with that of the controls (not
shown).
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levels of immuno£uorescence from those with low immuno-
£uorescence for Na channels in cell lines AT3 and MAT-
LyLu of the Dunning rat series. For MAT-LyLu cells, the
resulting frequency-distributions were similar and unimodal
with long ‘tails’ of high £uorescence extending to the right.
The proportion of positive cells was 8.8% from the low £uo-
rescence fraction and 4.7% from the high £uorescence frac-
tion. Frequency distributions from sorted AT3 cells were
markedly dissimilar (Fig. 4). The distribution derived from
cells with a low £uorescence was unimodal, whereas that
from the high £uorescence fraction was bimodal with a large
secondary peak (Fig. 4). The proportions of Na channel-
positive cells were 6.6% and 22.2%, (10.6% and 40.0% by
deconvolution), respectively.
4. Discussion
This investigation has demonstrated that Na channel pro-
teins are expressed by malignant prostate cells which have a
high metastatic ability. Our work not only extends the earlier
¢ndings of Grimes et al. [2] and Laniado et al. [1] to two
additional Dunning rat cell lines and two human prostate
carcinoma cell lines, but also provides new information relat-
ing expression of the Na channel to speci¢c genomic sequen-
ces derived from metastatic prostatic carcinoma cells.
By performing £ow cytometry on a large series of cell lines,
we have demonstrated that the proportion of cells expressing
Na channels correlates positively with their ability to invade
basement membrane matrix in vitro. With respect to the seven
cell lines of the Dunning rat series, the correlation was statisti-
cally signi¢cant only up to and including 27.2% of the cells
being invasive. With respect to the human prostate carcinoma
lines, the correlation was signi¢cant only up to 12.4% of the
cells being invasive. Two of the human cell lines, Du145 and
PC3, expressed positive Na channel immunoreactivity and
were highly invasive in vitro. Conversely, LNCaP is an an-
drogen-sensitive cell line which does not metastasise in nude
mice [8,18]. We found very few Na channels in cells from
this line and appropriately it scored zero on invasion assay,
¢ndings which concur with those of Laniado et al. [1]. How-
ever, the correlation between Na channel expression and
invasiveness was signi¢cant in a restricted range (0^12.4%)
of cells becoming invasive. This would imply that higher levels
of invasiveness may involve additional factors. Grimes et al.
[2] and Laniado et al. [1] also found that blocking Na chan-
nels with tetrodotoxin only partially suppressed invasion in
vitro. Thus, our in vitro studies suggest that the presence of
Na channels in prostate carcinoma may act as a marker of
metastatic ability.
The reason(s) for the observed discrepancies is not clear. In
the case of PNT2, a transformed cell line derived from normal
human prostatic epithelium which is reportedly benign but yet
exhibited numerous Na channels, transfection with the SV40
genome may confer upon the cells the ability to express Na
channels. Alternatively, PNT2 cells (and possibly other cell
lines) may require more than the observed 13.7% of Na
channel expression to become invasive. Another cell line,
RAMA 37, despite its benign nature, contained more cells
with Na channels than the malignant MAT-Lu line and
also scored highly in the invasion assay. It may be that,
although this cell line exhibits all the histopathological fea-
tures of a benign tumour in vivo, a proportion of its constit-
uent cells have the potential for invasion but are normally
prevented from doing so by local factors. It is also the only
line in our series which is entirely non-prostatic in origin.
Another possibility is that while expression of active Na
channels may be a prerequisite of the metastatic phenotype,
invasive and metastatic behaviour only occur in the circum-
stance that other essential criteria also have been ful¢lled. In
contrast to phenotypic appearances, which can be identi¢ed in
a progressive sequence from normal to malignant and ulti-
mately metastatic, genotypic abnormalities do not, necessar-
ily, occur in a concomitant sequence [19]. Thus, expression of
genes which ultimately trigger metastasis in prostate cancer,
and possibly in other epithelial malignancies, may occur early
in the phenotypic progression of a neoplasm but only become
manifest with the accumulation of other mutations [20].
Flow cytometric frequency-distributions of £uorescence in-
tensity were bimodal for those cell lines showing positive im-
munoreactivity, suggesting that cells which express Na chan-
nels form a distinct subpopulation. This observation is at
variance with that of Laniado et al. [1] who found no evidence
for a subpopulation of PC3 cells since the entire £ow cyto-
metric pro¢le was simply displaced to the right relative to the
control. Data derived from deconvolution of the histograms
indicate that the subpopulation expressing Na channels ac-
counts for as little as 5.1% of the total in AT2 cells to as much
as 45.6% in PC3 cells. On the whole, these percentages are
higher than those found by electrophysiology (0 and 10%,
respectively), implying that a ‘basal’ level of Na channels,
below the threshold for detection by patch-clamp recording,
exists in these cells.
We attempted to determine whether cells expressing high
levels of Na channel protein represent a distinct subpopula-
tion with an immutable phenotype or whether these cells co-
exist in equilibrium with their Na channel-negative neigh-
bours by sorting the cells into high and low £uorescence frac-
tions. If the cells are clonal in nature, £ow cytometric histo-
grams of the two fractions should re£ect the phenotype of the
originally sorted cells. This was con¢rmed for AT3 cells where
the progeny of a high £uorescence fraction contained an in-
creased proportion of positive cells whereas descendants of
the low £uorescence fraction did not. However, it is likely
that cells expressing Na channels are not a true subclone
of immutable phenotype otherwise all of the descendants of
the high £uorescence fraction in AT3 would have been immu-
nopositive (instead of only 22%). Nevertheless, it is of interest,
and potential biological importance, that the cells apparently
retain their phenotype for many divisions and only gradually
revert towards their original proportions within the popula-
tion.
Studies of the two transfectant cell lines, RMP1 and RMP2
indicate that when an epithelial cell is converted from benign
to malignant by a single genetic event, the transformation is
accompanied by spontaneous expression or upregulation of
Na channel protein. Of particular interest is the RMP1 cell
line where the recipient cell (RAMA 37) is totally benign in
vivo but contains moderate numbers of cells expressing Na
channels and the donor G cells is almost completely benign
(metastasis frequency 6 0.1%) and expresses few Na chan-
nels. The resulting transfectant line, however, is metastatic in
vivo [4], invasive in vitro and contains a high proportion of
cells expressing Na channels. This ¢nding suggests that the
genes involved in invasion and metastasis of prostate cancer
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cells are closely associated with those regulating expression of
Na channel proteins. However, the two transfectant cell lines
(RMP1 and RMP2) were not cloned prior to these experi-
ments and therefore, were likely to be of mixed genotype
containing cells of di¡ering metastatic potential. Inoculation
of these genetically heterogeneous cells into syngeneic rats
produced pulmonary metastases from which sublines
RMP1a-lu and RMP2c-lu were derived. It was anticipated
that this process would be selective for the metastatic malig-
nant genotypes and this appears to be valid since both cell
lines scored more highly on invasion assay and included more
cells with Na channels than their respective progenitors, par-
ticularly RMP2c-lu. This ¢nding adds further credence to
there being a close link between Na channels and metastatic
potential of prostate cancer cells. This postulated association
complements the growing evidence that a range of ion chan-
nels play important roles in promoting the metastatic process,
not only in prostate cancer but also in a wider range of epi-
thelial malignancies. Thus, Ca2-binding protein p9Ka has
been shown to be overexpressed in mammary cancers of
both mice [21] and humans [22] and transfection of the
p9Ka gene into previously benign rat mammary adenoma
cells (RAMA 37) induces a metastatic malignant phenotype
in a single step [23]. Recently we have shown that expression
of p9Ka mRNA by cell lines of the Dunning rat prostate
series increases proportionately with increasing malignant po-
tential of the cell lines in a manner comparable with the Na
channel immunoreactivity described in this paper [24]. Simi-
larly, expression of a newly recognised K channel by cells of
androgen-sensitive prostate cancer cell line LNCaP has been
correlated with increased cell proliferation [25]. Thus, we be-
lieve that there is a growing body of evidence indicating that
Na channel protein expression may be a useful marker for
metastatic potential in prostate cancer which, together with
other ion channel proteins, may have a close functional asso-
ciation with the malignant phenotype as a promotional event
in the development and progression of epithelial malignancies.
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